{"filing":{"accession_number":"0001628280-26-063594","cik":"0001417663","ticker":"SNWV","company_name":"SANUWAVE Health, Inc.","form":"8-K","filing_date":"2026-09-25","report_date":"2026-09-23","primary_document":"snwv-20260923.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026063594/snwv-20260923.htm"},"events":[{"id":35178,"run_id":32391,"accession_number":"0001628280-26-063594","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"Sanuwave received a Notice from Nasdaq on September 23, 2026, stating that its Market Value of Listed Securities (MVLS) fell below the $50,000,000 minimum required for continued listing on The Nasdaq Global Market under Listing Rule 5450(b)(2)(A). The company has 180 calendar days (until March 22, 2027) to regain compliance, and failure to do so will result in delisting notification. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the registrant's continued exchange listing status.","company_name":"SANUWAVE Health, Inc.","ticker":"SNWV","filing_date":"2026-09-25","form":"8-K","submitted_at":null,"items":[{"id":39135,"accession_number":"0001628280-26-063594","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Sanuwave received a Notice from Nasdaq on September 23, 2026, stating that its Market Value of Listed Securities (MVLS) fell below the $50,000,000 minimum required for continued listing on The Nasdaq Global Market under Listing Rule 5450(b)(2)(A). The company has 180 calendar days (until March 22, 2027) to regain compliance, and failure to do so will result in delisting notification. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the registrant's continued exchange listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T20:47:49.723329+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":39135,"accession_number":"0001628280-26-063594","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Sanuwave received a Notice from Nasdaq on September 23, 2026, stating that its Market Value of Listed Securities (MVLS) fell below the $50,000,000 minimum required for continued listing on The Nasdaq Global Market under Listing Rule 5450(b)(2)(A). The company has 180 calendar days (until March 22, 2027) to regain compliance, and failure to do so will result in delisting notification. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the registrant's continued exchange listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T20:47:49.723329+00:00","company_name":"SANUWAVE Health, Inc.","ticker":"SNWV","filing_date":"2026-09-25"}]}